Hall Laurie J Trustee Intercept Pharmaceuticals, Inc. Transaction History

Hall Laurie J Trustee

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 11, 2023	SELL	$11.61 - $16.11 $522 - $724	-45 Reduced 34.62%	85 $1,000
Q3 2022 Oct 11, 2022	BUY	$12.21 - $19.7 $488 - $788	40 Added 44.44%	130 $2,000
Q3 2021 Oct 04, 2021	SELL	$12.99 - $20.47 $649 - $1,023	-50 Reduced 35.71%	90 $1,000
Q3 2020 Oct 09, 2020	BUY	$39.09 - $53.44 $1,563 - $2,137	40 Added 40.0%	140 $6,000
Q4 2019 Feb 12, 2020	BUY	$57.36 - $124.1 $1,147 - $2,482	20 Added 25.0%	100 $12,000
Q3 2019 Oct 25, 2019	BUY	$58.69 - $80.46 $1,760 - $2,413	30 Added 60.0%	80 $5,000
Q4 2018 Feb 14, 2019	SELL	$85.79 - $126.46 $857 - $1,264	-10 Reduced 16.67%	50 $6,000
Q4 2017 Jan 30, 2018	BUY	$58.2 - $72.76 $3,492 - $4,365	60	60 $4,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

Stay updated on Hall Laurie J Trustee with notifications on news.